{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:09:58Z","timestamp":1788246598198,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,22]]},"DOI":"10.7759\/cureus.39350","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T19:35:17Z","timestamp":1684784117000},"source":"Crossref","is-referenced-by-count":6,"title":["A Systematic Review of the Role of Diet in Ulcerative Colitis"],"prefix":"10.7759","author":[{"given":"Nasir","family":"Abbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahrukh","family":"Shakil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeeshan","family":"Akhtar Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sardar","family":"Basharat Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammad","family":"Ayub Awan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saman","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.12627","article-title":"Ulcerative colitis narrative findings: Australian survey data comparing patient and physician disease management views","volume":"5","author":"Connor SJ","year":"2021","unstructured":"Connor SJ, Sechi A, Andrade M, Deuring JJ, Witcombe D. Ulcerative colitis narrative findings: Australian survey data comparing patient and physician disease management views. JGH Open. 2021, 5:1033-40. 10.1002\/jgh3.12627","journal-title":"JGH Open"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2018.08.006","article-title":"Management of ulcerative colitis in a real-life setting: an Italian multicenter, prospective, observational AIGO study","volume":"51","author":"Scribano ML","year":"2019","unstructured":"Scribano ML, Papi C, Costa F, et al.. Management of ulcerative colitis in a real-life setting: an Italian multicenter, prospective, observational AIGO study. Dig Liver Dis. 2019, 51:346-51. 10.1016\/j.dld.2018.08.006","journal-title":"Dig Liver Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/1751-2980.12837","article-title":"Factors associated with disability in patients with ulcerative colitis: a cross-sectional study","volume":"21","author":"Marinelli C","year":"2020","unstructured":"Marinelli C, Zingone F, Inferrera M, et al.. Factors associated with disability in patients with ulcerative colitis: a cross-sectional study. J Dig Dis. 2020, 21:81-7. 10.1111\/1751-2980.12837","journal-title":"J Dig Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/den.12744","article-title":"Pouchitis after ileal pouch-anal anastomosis in ulcerative colitis: diagnosis, management, risk factors, and incidence","volume":"29","author":"Hata K","year":"2017","unstructured":"Hata K, Ishihara S, Nozawa H, et al.. Pouchitis after ileal pouch-anal anastomosis in ulcerative colitis: diagnosis, management, risk factors, and incidence. Dig Endosc. 2017, 29:26-34. 10.1111\/den.12744","journal-title":"Dig Endosc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327811","article-title":"Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial","volume":"71","author":"Kedia S","year":"2022","unstructured":"Kedia S, Virmani S, K Vuyyuru S, et al.. Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial. Gut. 2022, 71:2401-13. 10.1136\/gutjnl-2022-327811","journal-title":"Gut"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab165","article-title":"Use of faecal transplantation with a novel diet for mild to moderate active ulcerative colitis: the CRAFT UC randomised controlled trial","volume":"16","author":"Sarbagili Shabat C","year":"2022","unstructured":"Sarbagili Shabat C, Scaldaferri F, Zittan E, et al.. Use of faecal transplantation with a novel diet for mild to moderate active ulcerative colitis: the CRAFT UC randomised controlled trial. J Crohns Colitis. 2022, 16:369-78. 10.1093\/ecco-jcc\/jjab165","journal-title":"J Crohns Colitis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/nxac093","article-title":"Therapeutic potential of the 4 strategies to SUlfide-REduction (4-SURE) diet in adults with mild to moderately active ulcerative colitis: an open-label feasibility study","volume":"152","author":"Day AS","year":"2022","unstructured":"Day AS, Yao CK, Costello SP, Ruszkiewicz A, Andrews JM, Gibson PR, Bryant RV. Therapeutic potential of the 4 strategies to SUlfide-REduction (4-SURE) diet in adults with mild to moderately active ulcerative colitis: an open-label feasibility study. J Nutr. 2022, 152:1690-701. 10.1093\/jn\/nxac093","journal-title":"J Nutr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001800","article-title":"Personalized research on diet in ulcerative colitis and Crohn's disease: a series of N-of-1 diet trials","volume":"117","author":"Kaplan HC","year":"2022","unstructured":"Kaplan HC, Opipari-Arrigan L, Yang J, et al.. Personalized research on diet in ulcerative colitis and Crohn's disease: a series of N-of-1 diet trials. Am J Gastroenterol. 2022, 117:902-17. 10.14309\/ajg.0000000000001800","journal-title":"Am J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/nu14163294","article-title":"Anti-inflammatory diet prevents subclinical colonic inflammation and alters metabolomic profile of ulcerative colitis patients in clinical remission","volume":"14","author":"Keshteli AH","year":"2022","unstructured":"Keshteli AH, Valcheva R, Nickurak C, et al.. Anti-inflammatory diet prevents subclinical colonic inflammation and alters metabolomic profile of ulcerative colitis patients in clinical remission. Nutrients. 2022, 14:3294. 10.3390\/nu14163294","journal-title":"Nutrients"},{"key":"ref10","article-title":"[Deficient lactose digestion and intolerance in a group of patients with chronic nonspecific ulcerative colitis: a controlled, double-blind, cross-over clinical trial]","volume":"77","author":"Cabrera-Acosta GA","year":"2012","unstructured":"Cabrera-Acosta GA, Milke-Garc\u00eda MP, Ram\u00edrez-Iglesias MT, Uscanga L. [Deficient lactose digestion and intolerance in a group of patients with chronic nonspecific ulcerative colitis: a controlled, double-blind, cross-over clinical trial]. Rev Gastroenterol Mex. 2012, 77:26-30.","journal-title":"Rev Gastroenterol Mex"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/18-220","article-title":"Relapse prevention by plant-based diet incorporated into induction therapy for ulcerative colitis: a single-group trial","volume":"23","author":"Chiba M","year":"2019","unstructured":"Chiba M, Nakane K, Tsuji T, et al.. Relapse prevention by plant-based diet incorporated into induction therapy for ulcerative colitis: a single-group trial. Perm J. 2019, 23:18-220. 10.7812\/TPP\/18-220","journal-title":"Perm J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/19.166","article-title":"High remission rate with infliximab and plant-based diet as first-line (IPF) therapy for severe ulcerative colitis: single-group trial","volume":"24","author":"Chiba M","year":"2020","unstructured":"Chiba M, Tsuji T, Nakane K, et al.. High remission rate with infliximab and plant-based diet as first-line (IPF) therapy for severe ulcerative colitis: single-group trial. Perm J. 2020, 24:1-10. 10.7812\/TPP\/19.166","journal-title":"Perm J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa097","article-title":"Multidimensional impact of Mediterranean diet on IBD patients","volume":"27","author":"Chicco F","year":"2021","unstructured":"Chicco F, Magr\u00ec S, Cingolani A, et al.. Multidimensional impact of Mediterranean diet on IBD patients. Inflamm Bowel Dis. 2021, 27:1-9. 10.1093\/ibd\/izaa097","journal-title":"Inflamm Bowel Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx073","article-title":"Fermentable carbohydrates [FODMAPs] exacerbate functional gastrointestinal symptoms in patients with inflammatory bowel disease: a randomised, double-blind, placebo-controlled, cross-over, re-challenge trial","volume":"11","author":"Cox SR","year":"2017","unstructured":"Cox SR, Prince AC, Myers CE, Irving PM, Lindsay JO, Lomer MC, Whelan K. Fermentable carbohydrates [FODMAPs] exacerbate functional gastrointestinal symptoms in patients with inflammatory bowel disease: a randomised, double-blind, placebo-controlled, cross-over, re-challenge trial. J Crohns Colitis. 2017, 11:1420-9. 10.1093\/ecco-jcc\/jjx073","journal-title":"J Crohns Colitis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.09.024","article-title":"Effects of low FODMAP diet on symptoms, fecal microbiome, and markers of inflammation in patients with quiescent inflammatory bowel disease in a randomized trial","volume":"158","author":"Cox SR","year":"2020","unstructured":"Cox SR, Lindsay JO, Fromentin S, et al.. Effects of low FODMAP diet on symptoms, fecal microbiome, and markers of inflammation in patients with quiescent inflammatory bowel disease in a randomized trial. Gastroenterology. 2020, 158:176-88.e7. 10.1053\/j.gastro.2019.09.024","journal-title":"Gastroenterology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/nu14204292","article-title":"Improving food-related quality of life in inflammatory bowel disease through a novel web resource: a feasibility randomised controlled trial","volume":"14","author":"Cox SR","year":"2022","unstructured":"Cox SR, Czuber-Dochan W, Wall CL, et al.. Improving food-related quality of life in inflammatory bowel disease through a novel web resource: a feasibility randomised controlled trial. Nutrients. 2022, 14:4292. 10.3390\/nu14204292","journal-title":"Nutrients"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.05.026","article-title":"Low-fat, high-fiber diet reduces markers of inflammation and dysbiosis and improves quality of life in patients with ulcerative colitis","volume":"19","author":"Fritsch J","year":"2021","unstructured":"Fritsch J, Garces L, Quintero MA, et al.. Low-fat, high-fiber diet reduces markers of inflammation and dysbiosis and improves quality of life in patients with ulcerative colitis. Clin Gastroenterol Hepatol. 2021, 19:1189-99.e30. 10.1016\/j.cgh.2020.05.026","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-010-1275-8","article-title":"Laparoendoscopic single-site surgery is feasible in complex colorectal resections and could enable day case colectomy","volume":"25","author":"Gash KJ","year":"2011","unstructured":"Gash KJ, Goede AC, Chambers W, Greenslade GL, Dixon AR. Laparoendoscopic single-site surgery is feasible in complex colorectal resections and could enable day case colectomy. Surg Endosc. 2011, 25:835-40. 10.1007\/s00464-010-1275-8","journal-title":"Surg Endosc"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3109\/00365513.2010.542484","article-title":"Salmon diet in patients with active ulcerative colitis reduced the simple clinical colitis activity index and increased the anti-inflammatory fatty acid index--a pilot study","volume":"71","author":"Grimstad T","year":"2011","unstructured":"Grimstad T, Berge RK, Bohov P, et al.. Salmon diet in patients with active ulcerative colitis reduced the simple clinical colitis activity index and increased the anti-inflammatory fatty acid index--a pilot study. Scand J Clin Lab Invest. 2011, 71:68-73. 10.3109\/00365513.2010.542484","journal-title":"Scand J Clin Lab Invest"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307198","article-title":"Abnormal fibre usage in UC in remission","volume":"64","author":"James SL","year":"2015","unstructured":"James SL, Christophersen CT, Bird AR, Conlon MA, Rosella O, Gibson PR, Muir JG. Abnormal fibre usage in UC in remission. Gut. 2015, 64:562-70. 10.1136\/gutjnl-2014-307198","journal-title":"Gut"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.2010.02057.x","article-title":"Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease?","volume":"310","author":"Jia W","year":"2010","unstructured":"Jia W, Whitehead RN, Griffiths L, et al.. Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease?. FEMS Microbiol Lett. 2010, 310:138-44. 10.1111\/j.1574-6968.2010.02057.x","journal-title":"FEMS Microbiol Lett"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy110","article-title":"Food exclusion based on IgG antibodies alleviates symptoms in ulcerative colitis: a prospective study","volume":"24","author":"Jian L","year":"2018","unstructured":"Jian L, Anqi H, Gang L, Litian W, Yanyan X, Mengdi W, Tong L. Food exclusion based on IgG antibodies alleviates symptoms in ulcerative colitis: a prospective study. Inflamm Bowel Dis. 2018, 24:1918-25. 10.1093\/ibd\/izy110","journal-title":"Inflamm Bowel Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i15.1773","article-title":"Safety and efficacy of Profermin\u00ae to induce remission in ulcerative colitis","volume":"18","author":"Krag A","year":"2012","unstructured":"Krag A, Israelsen H, von Ryberg B, Andersen KK, Bendtsen F. Safety and efficacy of Profermin\u00ae to induce remission in ulcerative colitis. World J Gastroenterol. 2012, 18:1773-80. 10.3748\/wjg.v18.i15.1773","journal-title":"World J Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000127","article-title":"A prospective, randomized, controlled, exploratory study of comprehensive dietary advice in ulcerative colitis: impact on disease activity and quality of life","volume":"26","author":"Kyaw MH","year":"2014","unstructured":"Kyaw MH, Moshkovska T, Mayberry J. A prospective, randomized, controlled, exploratory study of comprehensive dietary advice in ulcerative colitis: impact on disease activity and quality of life. Eur J Gastroenterol Hepatol. 2014, 26:910-7. 10.1097\/MEG.0000000000000127","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000585","article-title":"Dietary practices and beliefs in patients with inflammatory bowel disease","volume":"22","author":"Limdi JK","year":"2016","unstructured":"Limdi JK, Aggarwal D, McLaughlin JT. Dietary practices and beliefs in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016, 22:164-70. 10.1097\/MIB.0000000000000585","journal-title":"Inflamm Bowel Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/nu14061296","article-title":"Efficacy of FODMAP elimination and subsequent blinded placebo-controlled provocations in a randomised controlled study in patients with ulcerative colitis in remission and symptoms of irritable bowel syndrome: a feasibility study","volume":"14","author":"Melgaard D","year":"2022","unstructured":"Melgaard D, S\u00f8rensen J, Riis J, et al.. Efficacy of FODMAP elimination and subsequent blinded placebo-controlled provocations in a randomised controlled study in patients with ulcerative colitis in remission and symptoms of irritable bowel syndrome: a feasibility study. Nutrients. 2022, 14:1296. 10.3390\/nu14061296","journal-title":"Nutrients"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41430-019-0549-z","article-title":"The effects of extra virgin olive oil and canola oil on inflammatory markers and gastrointestinal symptoms in patients with ulcerative colitis","volume":"74","author":"Morvaridi M","year":"2020","unstructured":"Morvaridi M, Jafarirad S, Seyedian SS, Alavinejad P, Cheraghian B. The effects of extra virgin olive oil and canola oil on inflammatory markers and gastrointestinal symptoms in patients with ulcerative colitis. Eur J Clin Nutr. 2020, 74:891-9. 10.1038\/s41430-019-0549-z","journal-title":"Eur J Clin Nutr"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000638","article-title":"Dietary patterns and risk of inflammatory bowel disease in Europe: results from the EPIC study","volume":"22","author":"Racine A","year":"2016","unstructured":"Racine A, Carbonnel F, Chan SS, et al.. Dietary patterns and risk of inflammatory bowel disease in Europe: results from the EPIC study. Inflamm Bowel Dis. 2016, 22:345-54. 10.1097\/MIB.0000000000000638","journal-title":"Inflamm Bowel Dis"},{"key":"ref29","article-title":"[Probiotics\u2019 effectiveness on symptoms, histological features and feeding tolerance in ulcerative colitis]","volume":"57","author":"S\u00e1nchez-Morales A","year":"2019","unstructured":"S\u00e1nchez-Morales A, P\u00e9rez-Ayala MF, Cruz-Mart\u00ednez M, et al.. [Probiotics\u2019 effectiveness on symptoms, histological features and feeding tolerance in ulcerative colitis]. Rev Med Inst Mex Seguro Soc. 2019, 57:9-14.","journal-title":"Rev Med Inst Mex Seguro Soc"},{"key":"ref30","article-title":"[Serum metabolome by gas chromatography-mass spectrometry (GC-MS) in patients with ulcerative colitis and celiac disease]","author":"Sitkin SI","year":"2013","unstructured":"Sitkin SI, Tkachenko EI, Vakhitov TIa, Oreshko LS, Zhigalova TN. [Serum metabolome by gas chromatography-mass spectrometry (GC-MS) in patients with ulcerative colitis and celiac disease]. Eksp Klin Gastroenterol. 2013, 44-57.","journal-title":"Eksp Klin Gastroenterol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/apa.12215","article-title":"Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?","volume":"102","author":"Strisciuglio C","year":"2013","unstructured":"Strisciuglio C, Giannetti E, Martinelli M, Sciorio E, Staiano A, Miele E. Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatr. 2013, 102:e273-8. 10.1111\/apa.12215","journal-title":"Acta Paediatr"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1159\/000529318","article-title":"A regional survey of awareness of inflammatory bowel disease among the Saudi population","volume":"7","author":"Meeralam YK","year":"2023","unstructured":"Meeralam YK, Al Zanabgi A, Mosli M, et al.. A regional survey of awareness of inflammatory bowel disease among the Saudi population. Inflamm Intest Dis. 2023, 7:139-46. 10.1159\/000529318","journal-title":"Inflamm Intest Dis"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.7429\/pi.2020.733213","article-title":"The awareness of the IBD nurse position among patients from an Italian tertiary IBD centre","volume":"73","author":"Napolitano D","year":"2020","unstructured":"Napolitano D, Martella P, Schiavoni E, et al.. The awareness of the IBD nurse position among patients from an Italian tertiary IBD centre. Prof Inferm. 2020, 73:213-8. 10.7429\/pi.2020.733213","journal-title":"Prof Inferm"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.1088693","article-title":"Should the Mediterranean diet be recommended for inflammatory bowel diseases patients? A narrative review","volume":"9","author":"Ratajczak AE","year":"2022","unstructured":"Ratajczak AE, Festa S, Aratari A, Papi C, Dobrowolska A, Krela-Ka\u017amierczak I. Should the Mediterranean diet be recommended for inflammatory bowel diseases patients? A narrative review. Front Nutr. 2022, 9:1088693. 10.3389\/fnut.2022.1088693","journal-title":"Front Nutr"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i38.5862","article-title":"Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil","volume":"25","author":"Parra RS","year":"2019","unstructured":"Parra RS, Chebli JM, Amarante HM, et al.. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil. World J Gastroenterol. 2019, 25:5862-82. 10.3748\/wjg.v25.i38.5862","journal-title":"World J Gastroenterol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/nu14081591","article-title":"Inflammatory Bowel Disease and Reproductive Health: From Fertility to Pregnancy-A Narrative Review","volume":"14","author":"Ronchetti C","year":"2022","unstructured":"Ronchetti C, Cirillo F, Di Segni N, Cristodoro M, Busnelli A, Levi-Setti PE. Inflammatory Bowel Disease and Reproductive Health: From Fertility to Pregnancy-A Narrative Review. Nutrients. 2022, 14:1591. 10.3390\/nu14081591","journal-title":"Nutrients"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0000000000000881","article-title":"Impact of diet on hydrogen sulfide production: implications for gut health","volume":"26","author":"Teigen L","year":"2023","unstructured":"Teigen L, Biruete A, Khoruts A. Impact of diet on hydrogen sulfide production: implications for gut health. Curr Opin Clin Nutr Metab Care. 2023, 26:55-8. 10.1097\/MCO.0000000000000881","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029088","article-title":"Effects of low-FODMAP diet on irritable bowel symptoms in patients with quiescent inflammatory bowel disease: a protocol for a systematic review and meta-analysis","volume":"101","author":"Gu B","year":"2022","unstructured":"Gu B, Yu Z, Shi C, Yan C, Chen B, Zhou J. Effects of low-FODMAP diet on irritable bowel symptoms in patients with quiescent inflammatory bowel disease: a protocol for a systematic review and meta-analysis. Medicine (Baltimore). 2022, 101:e29088. 10.1097\/MD.0000000000029088","journal-title":"Medicine (Baltimore)"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/nu14102072","article-title":"A low-FODMAP diet provides benefits for functional gastrointestinal symptoms but not for improving stool consistency and mucosal inflammation in IBD: a systematic review and meta-analysis","volume":"14","author":"Peng Z","year":"2022","unstructured":"Peng Z, Yi J, Liu X. A low-FODMAP diet provides benefits for functional gastrointestinal symptoms but not for improving stool consistency and mucosal inflammation in IBD: a systematic review and meta-analysis. Nutrients. 2022, 14:2072. 10.3390\/nu14102072","journal-title":"Nutrients"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v8.i17.3786","article-title":"Awareness and attitude of fecal microbiota transplantation through transendoscopic enteral tubing among inflammatory bowel disease patients","volume":"8","author":"Zhong M","year":"2020","unstructured":"Zhong M, Sun Y, Wang HG, Marcella C, Cui BT, Miao YL, Zhang FM. Awareness and attitude of fecal microbiota transplantation through transendoscopic enteral tubing among inflammatory bowel disease patients. World J Clin Cases. 2020, 8:3786-96. 10.12998\/wjcc.v8.i17.3786","journal-title":"World J Clin Cases"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.887044","article-title":"Manipulation of gut microbiota as a key target for Crohn's disease","volume":"9","author":"Rashed R","year":"2022","unstructured":"Rashed R, Valcheva R, Dieleman LA. Manipulation of gut microbiota as a key target for Crohn's disease. Front Med (Lausanne). 2022, 9:887044. 10.3389\/fmed.2022.887044","journal-title":"Front Med (Lausanne)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2017-100936","article-title":"Faecal microbiota transplantation as a treatment for inflammatory bowel disease: a national survey of adult and paediatric gastroenterologists in the UK","volume":"9","author":"Mcilroy JR","year":"2018","unstructured":"Mcilroy JR, Nalagatla N, Hansen R, Hart A, Hold GL. Faecal microbiota transplantation as a treatment for inflammatory bowel disease: a national survey of adult and paediatric gastroenterologists in the UK. Frontline Gastroenterol. 2018, 9:250-5. 10.1136\/flgastro-2017-100936","journal-title":"Frontline Gastroenterol"},{"key":"ref43","article-title":"High-fat diet induces intestinal mucosal barrier dysfunction in ulcerative colitis: emerging mechanisms and dietary intervention perspective","volume":"15","author":"Jiang S","year":"2023","unstructured":"Jiang S, Miao Z. High-fat diet induces intestinal mucosal barrier dysfunction in ulcerative colitis: emerging mechanisms and dietary intervention perspective. Am J Transl Res. 2023, 15:653-77.","journal-title":"Am J Transl Res"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013589.pub2","article-title":"Interventions for the management of abdominal pain in ulcerative colitis","volume":"7","author":"Sinopoulou V","year":"2021","unstructured":"Sinopoulou V, Gordon M, Dovey TM, Akobeng AK. Interventions for the management of abdominal pain in ulcerative colitis. Cochrane Database Syst Rev. 2021, 7:CD013589. 10.1002\/14651858.CD013589.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i4.682","article-title":"Gaseous metabolites as therapeutic targets in ulcerative colitis","volume":"29","author":"Yao CK","year":"2023","unstructured":"Yao CK, Sarbagili-Shabat C. Gaseous metabolites as therapeutic targets in ulcerative colitis. World J Gastroenterol. 2023, 29:682-91. 10.3748\/wjg.v29.i4.682","journal-title":"World J Gastroenterol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3390\/nu11040931","article-title":"Dietary factors in sulfur metabolism and pathogenesis of ulcerative colitis","volume":"11","author":"Teigen LM","year":"2019","unstructured":"Teigen LM, Geng Z, Sadowsky MJ, Vaughn BP, Hamilton MJ, Khoruts A. Dietary factors in sulfur metabolism and pathogenesis of ulcerative colitis. Nutrients. 2019, 11:931. 10.3390\/nu11040931","journal-title":"Nutrients"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3390\/nu14122469","article-title":"Nutrition and supplementation in ulcerative colitis","volume":"14","author":"Radziszewska M","year":"2022","unstructured":"Radziszewska M, Smarkusz-Zarzecka J, Ostrowska L, Pogodzi\u0144ski D. Nutrition and supplementation in ulcerative colitis. Nutrients. 2022, 14:2469. 10.3390\/nu14122469","journal-title":"Nutrients"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3390\/nu13061780","article-title":"The microbiome as a therapy in pouchitis and ulcerative colitis","volume":"13","author":"LeBlanc JF","year":"2021","unstructured":"LeBlanc JF, Segal JP, de Campos Braz LM, Hart AL. The microbiome as a therapy in pouchitis and ulcerative colitis. Nutrients. 2021, 13:1780. 10.3390\/nu13061780","journal-title":"Nutrients"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/154638-a-systematic-review-of-the-role-of-diet-in-ulcerative-colitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:34Z","timestamp":1707508894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/154638-a-systematic-review-of-the-role-of-diet-in-ulcerative-colitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,22]]},"references-count":48,"URL":"https:\/\/doi.org\/10.7759\/cureus.39350","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,22]]}}}